Matches in SemOpenAlex for { <https://semopenalex.org/work/W189363407> ?p ?o ?g. }
- W189363407 abstract "The ABCB1 transporter (P-glycoprotein), an ATP-driven efflux protein, strongly influences the absorption, distribution and excretion of various drugs. As an essential component of the blood-brain barrier, P-glycoprotein limits the penetration of potent cytostatic agents (e.g. paclitaxel) into the central nervous system (CNS). Furthermore, over-expression of ABCB1 transporters in tumor cells is one of the major mechanisms of classical multidrug resistance (MDR) in cancer. Hence, inhibition of P glycoprotein is an attractive strategy to improve the therapy of both, tumors in the CNS and MDR malignancies in the periphery.Accordingly, a series of potent inhibitors derived from the 3rd generation P-glycoprotein modulator tariquidar was investigated in vitro. A fluorescence-based efflux-assay using human Kb-V1 cells was established at the microtiter plate format. The obtained data were in good agreement with the validated flow cytometric method while throughput was substantially increased. Additionally, cells expressing the murine transporter were generated to assure activity at rodent P-glycoprotein. Further biopharmaceutical investigations (concerning toxicity, stability, plasma albumin binding and inhibition of cytochrome P450 isoenzymes) confirmed the suitability of tariquidar and the three most promising derivatives (bearing polar residues such as a methoxyethoxyethylamino (ME27-4), a morpholino (ME30-1) or an ethoxyethyloxy (ME33-1) moiety) for further in vivo studies.In order to determine the concentration of the selected modulators in brain and plasma samples, a solid-phase extraction procedure followed by RP-HPLC analysis was established and validated. The method yielded reproducible high recoveries, a low limit of quantification as well as high accuracy and precision. The concomitant administration of paclitaxel in successive bio-distribution studies in NMRI mice revealed favorable bioavailability and high metabolic stability of the tariquidar-like compounds. As desired, the modulators significantly increased the brain AUC of paclitaxel. The observed increase by a factor of two to four correlated with the previously determined in vitro potency of the various inhibitors. In contrast to the co-administration of the 2nd generation modulator valspodar, the plasma AUC of paclitaxel was unaffected, indicating lower systemic toxicity.To investigate if the increased paclitaxel brain concentration is of relevance for the therapy of malignant brain tumors, an intracerebral xenograft model in nude mice was refined. Human U 118 MG glioblastoma cells were transfected with the genes encoding for the far-red fluorescent protein or the luciferase2 (Luc2) enzyme to facilitate non-invasive determination of tumor burden by means of fluorescence or bioluminescence imaging (BLI). Tumors originating from intracerebral injection of luciferase2 expressing cells were detectable in the living animal. Unfortunately, the growth behavior was unsuitable for the intended in vivo investigations. Alternatively, highly tumorigenic U 87-Luc2 xenografts were utilized for subsequent treatment experiments evaluating the combination of paclitaxel with the most potent modulators ME33-1 or tariquidar. Since the obtained light signals largely correlated with the histological determined tumor burden, BLI revealed a moderate retardation of tumor progression when paclitaxel was combined with an ABCB1 modulator.Furthermore, the therapeutic value of the co-administration of ABCB1 modulators with paclitaxel in the treatment of MDR tumors was investigated. For this purpose, ABCB1 transporter over-expressing Kb-V1 cells were extensively characterized in vitro followed by subcutaneous implantation into nude mice. The resulting malignancies showed high tumorigenicity, reproducible growth kinetics and maintained transporter expression in vivo. In subsequent treatment experiments ME30-1, ME33-1 and tariquidar were investigated. In contrast to the other modulators, only the combination of ME30-1 with paclitaxel significantly slowed down the growth of Kb-V1 tumors compared to paclitaxel mono-therapy.Additionally, molecular modeling investigations were performed based on the very recently published x-ray structure of the murine Abcb1a transporter. Conformational analysis of the tariquidar-like modulators provided the starting conformation for successive docking experiments. The location of the subsequently identified binding region is in accordance with the suggested transport mechanism and experimental data from the literature. The proposed binding modes largely agree with the inhibitory potencies of the investigated ABCB1 modulators and explain the negligible ABCB1 activity of tariquidar-derived, selective ABCG2 modulators. The findings facilitate the structure based design of optimized ABCB1 modulators and may contribute to improve the adjuvant cancer chemotherapy of glioblastomas and MDR tumors." @default.
- W189363407 created "2016-06-24" @default.
- W189363407 creator A5058675509 @default.
- W189363407 date "2010-07-19" @default.
- W189363407 modified "2023-09-27" @default.
- W189363407 title "New tariquidar-like ABCB1 modulators in cancer chemotherapy:Preclinical pharmacokinetic, pharmacodynamic investigations and computational studies" @default.
- W189363407 cites W102428806 @default.
- W189363407 cites W106690969 @default.
- W189363407 cites W120778686 @default.
- W189363407 cites W1485007245 @default.
- W189363407 cites W1491459594 @default.
- W189363407 cites W1511853133 @default.
- W189363407 cites W1513102809 @default.
- W189363407 cites W1519177607 @default.
- W189363407 cites W1526950891 @default.
- W189363407 cites W1529837192 @default.
- W189363407 cites W1587690368 @default.
- W189363407 cites W1593652087 @default.
- W189363407 cites W1594196316 @default.
- W189363407 cites W1598654033 @default.
- W189363407 cites W1623543107 @default.
- W189363407 cites W1668393581 @default.
- W189363407 cites W167845783 @default.
- W189363407 cites W1798337468 @default.
- W189363407 cites W1807250678 @default.
- W189363407 cites W1834241234 @default.
- W189363407 cites W1910056530 @default.
- W189363407 cites W1916389172 @default.
- W189363407 cites W1934127833 @default.
- W189363407 cites W1961820026 @default.
- W189363407 cites W1964470226 @default.
- W189363407 cites W1964907928 @default.
- W189363407 cites W1968468357 @default.
- W189363407 cites W1968769447 @default.
- W189363407 cites W1970721581 @default.
- W189363407 cites W1973544766 @default.
- W189363407 cites W1976815300 @default.
- W189363407 cites W1977253304 @default.
- W189363407 cites W1977584573 @default.
- W189363407 cites W1978612710 @default.
- W189363407 cites W1980418252 @default.
- W189363407 cites W1983739049 @default.
- W189363407 cites W1984820569 @default.
- W189363407 cites W1984939118 @default.
- W189363407 cites W1988605167 @default.
- W189363407 cites W1989064705 @default.
- W189363407 cites W1991099559 @default.
- W189363407 cites W1992468039 @default.
- W189363407 cites W1992875306 @default.
- W189363407 cites W1993373855 @default.
- W189363407 cites W1995783411 @default.
- W189363407 cites W1997635067 @default.
- W189363407 cites W1997696660 @default.
- W189363407 cites W1999558499 @default.
- W189363407 cites W2004934711 @default.
- W189363407 cites W2005779465 @default.
- W189363407 cites W2006998103 @default.
- W189363407 cites W2007279146 @default.
- W189363407 cites W2012915029 @default.
- W189363407 cites W2013449127 @default.
- W189363407 cites W2014293907 @default.
- W189363407 cites W2014896707 @default.
- W189363407 cites W2018522485 @default.
- W189363407 cites W2020441233 @default.
- W189363407 cites W2021805364 @default.
- W189363407 cites W2025907258 @default.
- W189363407 cites W2026398446 @default.
- W189363407 cites W2028533496 @default.
- W189363407 cites W2030281462 @default.
- W189363407 cites W2033020367 @default.
- W189363407 cites W2033346155 @default.
- W189363407 cites W2034957642 @default.
- W189363407 cites W2034979953 @default.
- W189363407 cites W2035253718 @default.
- W189363407 cites W2037834300 @default.
- W189363407 cites W2038247317 @default.
- W189363407 cites W2040004169 @default.
- W189363407 cites W2041417130 @default.
- W189363407 cites W2041833179 @default.
- W189363407 cites W2044968828 @default.
- W189363407 cites W2045266358 @default.
- W189363407 cites W2047282772 @default.
- W189363407 cites W2048109742 @default.
- W189363407 cites W2048748629 @default.
- W189363407 cites W2049147399 @default.
- W189363407 cites W2050395817 @default.
- W189363407 cites W2050424784 @default.
- W189363407 cites W2051962690 @default.
- W189363407 cites W2055904567 @default.
- W189363407 cites W2057864075 @default.
- W189363407 cites W2058052390 @default.
- W189363407 cites W2060578335 @default.
- W189363407 cites W2061600887 @default.
- W189363407 cites W2064920658 @default.
- W189363407 cites W2065895412 @default.
- W189363407 cites W2066470751 @default.
- W189363407 cites W2066523050 @default.
- W189363407 cites W2069118421 @default.
- W189363407 cites W2070116427 @default.
- W189363407 cites W2072373055 @default.